{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-378838","form_type":"8-K","ticker":"PMVP","cik":"0001699382","company_name":"PMV Pharmaceuticals, Inc.","filed_at":"2026-09-01T22:23:31+00:00","discovered_at":"2026-09-02T10:05:00.404834+00:00","generated_at":"2026-09-02T10:05:43.956753+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"PMV Pharma prices $50.8M public offering of common stock and warrants","bullets":["Priced offering of 22,055,000 shares and pre-funded warrants for 19,900,000 shares, each with accompanying warrants for 41,955,000 shares total.","Combined offering price $1.21 per share/warrant; gross proceeds ~$50.8M, net ~$47.0M.","Proceeds to fund late-stage development, regulatory submission, and commercialization prep for rezatapopt.","Warrants exercisable immediately, expire in 5 years; exercise price resets to 33% of initial upon FDA acceptance of rezatapopt NDA.","Offering expected to close September 2, 2026; TD Cowen sole book-runner."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-378838","json":"https://secwatch.observer/filing/0001193125-26-378838.json","markdown":"https://secwatch.observer/filing/0001193125-26-378838.md","text":"https://secwatch.observer/filing/0001193125-26-378838.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699382/000119312526378838/0001193125-26-378838-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699382/000119312526378838/d113784d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T10:05:43.956753+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}